|
|
||||||||

*
Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, MA 01655; and
Biogen, Cambridge, MA 02142
Replication-defective adenoviruses are effective vehicles for gene transfer, both for the repair of defective genes and for studies of gene function in primary cells. Many cell types, including lymphocytes, are refractory to adenovirus infection because they lack the Coxsackie/adenovirus receptor (CAR) needed for virus attachment. To extend the advantages of adenovirus-mediated gene transfer to primary lymphoid populations and other cell types lacking endogenous CAR, we produced a mouse that expresses human (h) CAR as a transgene under control of a murine MHC class I promoter. hCAR protein is expressed on T and B lymphocytes from a variety of organs (spleen, lymph node, bone marrow, thymus, and peritoneum). These lymphocytes are susceptible to adenovirus infection, as demonstrated by reporter green fluorescent protein gene expression, with the fraction of expressing cells as high as 70%. Some lymphocyte subpopulations required stimulation subsequent to adenovirus infection for reporter expression. This activation requirement is a restriction imposed by the promoter used in the adenovirus construct. In subpopulations requiring activation, the elongation factor 1 promoter was far superior to a hCMV promoter for directing green fluorescent protein production. We also find that hCAR mRNA is produced in nonlymphoid tissues from all founder lines, including tissues that do not express endogenous murine CAR, suggesting the opportunity for effecting gene delivery to and testing gene function in a wide variety of primary cell types previously resistant to gene transfer.
This article has been cited by other articles:
![]() |
C. A. Shaw, N. Larochelle, R. W.R. Dudley, H. Lochmuller, G. Danialou, B. J. Petrof, G. Karpati, P. C. Holland, and J. Nalbantoglu Simultaneous Dystrophin and Dysferlin Deficiencies Associated with High-Level Expression of the Coxsackie and Adenovirus Receptor in Transgenic Mice Am. J. Pathol., December 1, 2006; 169(6): 2148 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Toh, S.-S. Hong, F. v. d. Loo, L. Franqueville, L. Lindholm, W. v. d. Berg, P. Boulanger, and P. Miossec Enhancement of Adenovirus-Mediated Gene Delivery to Rheumatoid Arthritis Synoviocytes and Synovium by Fiber Modifications: Role of Arginine-Glycine-Aspartic Acid (RGD)- and Non-RGD-Binding Integrins J. Immunol., December 1, 2005; 175(11): 7687 - 7698. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and J. M. Bergelson Adenovirus Receptors J. Virol., October 1, 2005; 79(19): 12125 - 12131. [Full Text] [PDF] |
||||
![]() |
F. Kuhnel, B. Schulte, T. Wirth, N. Woller, S. Schafers, L. Zender, M. Manns, and S. Kubicka Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors J. Virol., December 15, 2004; 78(24): 13743 - 13754. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bhattacharya, E. C. Logue, S. Bakkour, J. DeGregori, and W. C. Sha Identification of gene function by cyclical packaging rescue of retroviral cDNA libraries PNAS, June 25, 2002; 99(13): 8838 - 8843. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Cohen, Z. Q. Xiang, G.-P. Gao, H. C. J. Ertl, J. M. Wilson, and J. M. Bergelson Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor J. Gen. Virol., January 1, 2002; 83(1): 151 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vos, A. Neubert, E. Pommerening, T. Muller, L. Dohner, L. Neubert, and K. Hughes Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration J. Gen. Virol., September 1, 2001; 82(9): 2191 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tallone, S. Malin, A. Samuelsson, J. Wilbertz, M. Miyahara, K. Okamoto, L. Poellinger, L. Philipson, and S. Pettersson A mouse model for adenovirus gene delivery PNAS, July 3, 2001; 98(14): 7910 - 7915. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |